Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients
Clinical trial NCT04565496 · WITHDRAWN
Trial details
- NCT number
- NCT04565496
- Sponsor
- IRCCS San Raffaele
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-10
- Primary completion
- 2025-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.